Obituaries
PGe
PG Store
Archives
Classifieds
Classified
Events
Jobs
Real Estate
Legal Notices
Pets
MENU
SUBSCRIBE
LOGIN
REGISTER
LOG OUT
MY PROFILE
Home
News
Local
Sports
Opinion
A&E
Life
Business
Contact Us
NEWSLETTERS
MENU
ACCOUNT
Subscribe
Login
Register
Log out
My Profile
Subscriber Services
Search
SECTIONS
HOME
Homepage
This Just In
Chats
Weather
Traffic
Event Guide
PG Store
PGe
Video
Photos
The Digs
RSS Feeds
NEWS
News Home
COVID-19
World
Nation
State
Obituaries
News Obituaries
Politics
Education
Portfolio
Science
Health & Wellness
Environment
Aging Edge
Transportation
Faith & Religion
Crimes & Courts
Social Services
LOCAL
Local Home
Region
City
North
East
West
South
Washington
Westmoreland
The Neighborhood
Obituaries
Classifieds
Legal Notices
Real Estate
SPORTS
Sports Home
Steelers
Penguins
Pirates
Sports Columns
Gene Collier
Ron Cook
Joe Starkey
Paul Zeise
High School Sports
College Sports
Pitt
Penn State
WVU
NCAA
NFL
MLB
NBA
NHL
North Shore Drive Podcast
OPINION
Opinion Home
Editorials
Letters
Op-Ed Columns
PG Columnists
Insight
A&E
A&E Home
Celebrities
Movies
TV & Radio
Music
Concert Listings
Theatre & Dance
Art & Architecture
Books
Events
LIFE
Life Home
Food
Buying Here
Homes & Gardens
Style & Fashion
Travel
Restaurants
Seen
goodness
Random Acts of Kindness
Pets
Beer Me
Outdoors
Holidays
BUSINESS
Business Home
Your Money
Wheels
Workzone
Business Health
Tech News
Building PGH
Powersource
Business / Law
Top Workplaces
Business of Pittsburgh
Consumer Alerts
OTHER
PGe
NEWSLETTERS
PG STORE
ARCHIVES
CLASSIFIEDS
OBITUARIES
JOBS
LEGAL NOTICES
REAL ESTATE
CLASSIFIEDS
EVENTS
PETS
CONTACT US / FAQ
CONTACT US
ADVERTISING
CAREER OPPORTUNITIES
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
(OP:
POLBF
)
0.0425
UNCHANGED
Last Price
Updated: 11:43 AM EDT, Jul 10, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about POLBF
< Previous
1
2
3
Next >
Poolbeg Pharma PLC Announces Interim Results for the Six Months to 30 June 2023
September 13, 2023
Via
ACCESSWIRE
Poolbeg Pharma and CytoReason identify "very exciting influenza targets"
June 29, 2023
Poolbeg Pharma and CytoReason identify "very exciting influenza targets"
Via
News Direct
Topics
Artificial Intelligence
Poolbeg Pharma and CytoReason identify "very exciting influenza targets"
June 29, 2023
Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) CEO Jeremy Skillington and CytoReason co-founder and CEO David Harel speak to Thomas Warner from Proactive after announcing what they call a "significant...
Via
TheNewswire.com
Topics
Artificial Intelligence
Poolbeg Pharma PLC Announces AI Led Programme Identifies Influenza Drug Targets
June 29, 2023
Via
ACCESSWIRE
Poolbeg Pharma PLC - Oral Vaccine Programme Moves Forward
June 22, 2023
Via
ACCESSWIRE
Poolbeg Pharma PLC Announces Annual Report & AGM Notice
April 12, 2023
Via
ACCESSWIRE
Poolbeg Pharma PLC Announces Results for the Year Ended 31 December 2022
March 30, 2023
Via
ACCESSWIRE
Poolbeg Pharma PLC Announces Strategic Expansion of POLB 001 into Oncology
January 16, 2023
Via
ACCESSWIRE
Poolbeg Pharma sees "significant commercial opportunity" in oral vaccines
June 22, 2023
Poolbeg Pharma sees "significant commercial opportunity" in oral vaccines
Via
News Direct
Poolbeg Pharma sees "significant commercial opportunity" in oral vaccines
June 22, 2023
Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) CEO Jeremy Skillington speaks to Thomas Warner from Proactive after announcing that work on the company's Oral Vaccine Programme collaboration is now set to...
Via
TheNewswire.com
Poolbeg Pharma PLC Announces Board Appointment
May 24, 2023
Via
ACCESSWIRE
Poolbeg Pharma PLC Announces Results of Annual General Meeting
May 11, 2023
Via
ACCESSWIRE
Poolbeg Pharma PLC Announces Positive Initial Data Analysis in POLB 001 Trial
January 09, 2023
Via
ACCESSWIRE
Poolbeg Identifies Novel RSV Drug Candidates
December 21, 2022
Via
ACCESSWIRE
Poolbeg Pharma PLC Announces Metabolic Diseases Oral Delivery Licence Signed
December 14, 2022
Via
ACCESSWIRE
Poolbeg Pharma PLC - POLB 001 LPS Human Challenge Trial Completed
December 12, 2022
Via
ACCESSWIRE
Poolbeg Pharma "in a very healthy cash position" after first full year of operations
March 30, 2023
Poolbeg Pharma "in a very healthy cash position" after first full year of operations
Via
News Direct
Poolbeg Pharma "in a very healthy cash position" after first full year of operations
March 30, 2023
Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) CEO Jeremy Skillington speaks to Proactive after publishing final results for 2022 that show that the clinical-stage biotech company finished its first full...
Via
TheNewswire.com
Proactive's Robin Davison publishes fresh research note on Poolbeg Pharma
March 09, 2023
Proactive's Robin Davison publishes fresh research note on Poolbeg Pharma
Via
News Direct
Proactive's Robin Davison publishes fresh research note on Poolbeg Pharma
March 09, 2023
Proactive research analyst Robin Davison speaks to Thomas Warner after publishing a new report on Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF), following the release of selected data from its human...
Via
TheNewswire.com
Poolbeg Pharma "couldn't be happier" with POLB 001 human challenge trial data
March 02, 2023
Poolbeg Pharma "couldn't be happier" with POLB 001 human challenge trial data
Via
News Direct
Poolbeg Pharma PLC Announces Influenza AI model build completed
November 29, 2022
Via
ACCESSWIRE
Poolbeg Pharma "couldn't be happier" with POLB 001 human challenge trial data
March 02, 2023
Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) CEO Jeremy Skillington speaks to Proactive's Thomas Warner after announcing the data readout from an LPS human challenge trial for POLB 001, the infectious...
Via
TheNewswire.com
Poolbeg Pharma "really open" to different types of deal for POLB 001
March 01, 2023
Poolbeg Pharma "really open" to different types of deal for POLB 001
Via
News Direct
Poolbeg Pharma "really open" to different types of deal for POLB 001
March 01, 2023
Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) VP of Business Development David English speaks to Proactive's Thomas Warner about the work he's doing to progress the clinical stage infectious disease...
Via
TheNewswire.com
Poolbeg Pharma announces expansion of POLB 001 into oncology
January 18, 2023
Poolbeg Pharma announces expansion of POLB 001 into oncology
Via
News Direct
Topics
Intellectual Property
Poolbeg Pharma announces expansion of POLB 001 into oncology
January 18, 2023
Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) CEO Jeremy Skillington speaks to Proactive's Thomas Warner after announcing that the company has submitted a patent application for the use of POLB 001 in a...
Via
TheNewswire.com
Topics
Intellectual Property
Poolbeg Pharma upbeat on preliminary influenza drug results
January 09, 2023
Poolbeg Pharma upbeat on preliminary influenza drug results
Via
News Direct
Poolbeg Pharma upbeat on preliminary influenza drug results
January 09, 2023
Poolbeg Pharma PLC (OTCQB:POLBF) CEO Jeremy Skillington speaks to Proactive after announcing initial data analysis, including a 'clear dose-related response', for its drug, POLB 001, a potential...
Via
TheNewswire.com
Poolbeg Pharma PLC Announces Capital Markets Day
November 17, 2022
Via
ACCESSWIRE
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
TOP
Email a Story
Your e-mail:
Friends e-mail:
Submit
